JP7176230B2 - 投薬管理装置、投薬管理方法及び投薬管理プログラム - Google Patents
投薬管理装置、投薬管理方法及び投薬管理プログラム Download PDFInfo
- Publication number
- JP7176230B2 JP7176230B2 JP2018102327A JP2018102327A JP7176230B2 JP 7176230 B2 JP7176230 B2 JP 7176230B2 JP 2018102327 A JP2018102327 A JP 2018102327A JP 2018102327 A JP2018102327 A JP 2018102327A JP 7176230 B2 JP7176230 B2 JP 7176230B2
- Authority
- JP
- Japan
- Prior art keywords
- medication
- information
- unit
- drug
- period
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims description 778
- 229940079593 drug Drugs 0.000 title claims description 697
- 238000007726 management method Methods 0.000 title claims description 309
- 230000015654 memory Effects 0.000 claims description 51
- 238000000034 method Methods 0.000 claims description 44
- 206010020772 Hypertension Diseases 0.000 claims description 23
- 238000004364 calculation method Methods 0.000 claims description 16
- 230000006870 function Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 description 161
- 230000036772 blood pressure Effects 0.000 description 77
- 238000004891 communication Methods 0.000 description 47
- 238000005259 measurement Methods 0.000 description 37
- 238000009530 blood pressure measurement Methods 0.000 description 32
- 238000012545 processing Methods 0.000 description 27
- 230000008569 process Effects 0.000 description 26
- 238000003745 diagnosis Methods 0.000 description 24
- 230000035487 diastolic blood pressure Effects 0.000 description 19
- 230000035488 systolic blood pressure Effects 0.000 description 19
- 201000010099 disease Diseases 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 238000010586 diagram Methods 0.000 description 15
- 208000024891 symptom Diseases 0.000 description 14
- 238000013500 data storage Methods 0.000 description 10
- 230000001133 acceleration Effects 0.000 description 8
- 230000001788 irregular Effects 0.000 description 8
- 239000000470 constituent Substances 0.000 description 7
- 239000002220 antihypertensive agent Substances 0.000 description 5
- 229940127088 antihypertensive drug Drugs 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 208000017574 dry cough Diseases 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 208000033830 Hot Flashes Diseases 0.000 description 3
- 206010060800 Hot flush Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000005541 ACE inhibitor Substances 0.000 description 2
- 229940127291 Calcium channel antagonist Drugs 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
- 229940127282 angiotensin receptor antagonist Drugs 0.000 description 1
- 229940125364 angiotensin receptor blocker Drugs 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 230000010365 information processing Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003451 thiazide diuretic agent Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000003936 working memory Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018102327A JP7176230B2 (ja) | 2018-05-29 | 2018-05-29 | 投薬管理装置、投薬管理方法及び投薬管理プログラム |
| CN201980028846.7A CN112041935A (zh) | 2018-05-29 | 2019-05-21 | 用药管理装置、用药管理方法及用药管理程序 |
| DE112019002084.6T DE112019002084T5 (de) | 2018-05-29 | 2019-05-21 | Medikationsverwaltungsvorrichtung, medikationsverwaltungsverfahren und medikationsverwaltungsprogramm |
| PCT/JP2019/020056 WO2019230494A1 (ja) | 2018-05-29 | 2019-05-21 | 投薬管理装置、投薬管理方法及び投薬管理プログラム |
| US17/101,867 US20210118539A1 (en) | 2018-05-29 | 2020-11-23 | Medication management device, medication management method, and non-transitory computer-readable storage medium storing medication management program |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018102327A JP7176230B2 (ja) | 2018-05-29 | 2018-05-29 | 投薬管理装置、投薬管理方法及び投薬管理プログラム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019207537A JP2019207537A (ja) | 2019-12-05 |
| JP2019207537A5 JP2019207537A5 (enExample) | 2021-07-26 |
| JP7176230B2 true JP7176230B2 (ja) | 2022-11-22 |
Family
ID=68696979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018102327A Active JP7176230B2 (ja) | 2018-05-29 | 2018-05-29 | 投薬管理装置、投薬管理方法及び投薬管理プログラム |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210118539A1 (enExample) |
| JP (1) | JP7176230B2 (enExample) |
| CN (1) | CN112041935A (enExample) |
| DE (1) | DE112019002084T5 (enExample) |
| WO (1) | WO2019230494A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7149665B2 (ja) | 2020-03-30 | 2022-10-07 | 株式会社Peco | 動物患者用電子カルテの提供方法 |
| JP2022024728A (ja) * | 2020-07-28 | 2022-02-09 | オムロンヘルスケア株式会社 | 血圧関連情報表示装置、血圧関連情報表示方法、およびプログラム |
| JP7468224B2 (ja) | 2020-07-28 | 2024-04-16 | オムロンヘルスケア株式会社 | 血圧関連情報表示装置、血圧関連情報表示方法、およびプログラム |
| JP7326385B2 (ja) * | 2021-06-30 | 2023-08-15 | 西日本電信電話株式会社 | 情報提供システム、情報加工装置、情報提供装置、情報提供方法及びコンピュータプログラム |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003323497A (ja) | 2002-04-30 | 2003-11-14 | Moss Institute Co Ltd | 投薬管理システム及び情報処理装置、投薬管理方法並びにプログラム |
| JP2013105302A (ja) | 2011-11-14 | 2013-05-30 | Mvisual Co Ltd | 調剤薬局システム |
| US20150058035A1 (en) | 2013-08-23 | 2015-02-26 | Ateb, Inc. | Methods, systems and computer program products for automatic periodic prescription fill dates |
| JP2016531334A (ja) | 2013-06-06 | 2016-10-06 | ヤンセン ファーマシューティカ エヌ.ベー. | 電気的服薬アドヒアランス、識別、及び分配 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2930548B2 (ja) * | 1996-02-29 | 1999-08-03 | 株式会社塚田メディカル・リサーチ | 携帯式患者用服薬管理ボード |
| JP2002056099A (ja) * | 2000-08-11 | 2002-02-20 | Ntt Me Corp | 健康管理システム |
| JP2004265105A (ja) * | 2003-02-28 | 2004-09-24 | Mitsubishi Electric Information Systems Corp | 投薬状況管理システム及び投薬状況管理プログラム |
| US20130317839A1 (en) * | 2012-03-16 | 2013-11-28 | Drfirst.Com, Inc. | System and method for increasing patient adherence to medication treatment regimens |
| JP2014071592A (ja) * | 2012-09-28 | 2014-04-21 | Fujifilm Corp | 投薬効果予測システム及びその制御方法、並びに制御プログラム |
| JP3185839U (ja) * | 2013-06-25 | 2013-09-05 | 株式会社ウエルテクノス | 糖尿病治療困難者支援システム及び肥満症治療困難者支援システム |
| JP2015060509A (ja) * | 2013-09-20 | 2015-03-30 | 株式会社Sdネクスト | 服薬管理システム |
| JP2016091419A (ja) * | 2014-11-07 | 2016-05-23 | 株式会社Nttドコモ | 端末装置、服薬支援方法、プログラム |
| US10255412B2 (en) * | 2015-11-13 | 2019-04-09 | Reciprocal Labs Corporation | Real time adaptive controller medication dosing |
-
2018
- 2018-05-29 JP JP2018102327A patent/JP7176230B2/ja active Active
-
2019
- 2019-05-21 WO PCT/JP2019/020056 patent/WO2019230494A1/ja not_active Ceased
- 2019-05-21 DE DE112019002084.6T patent/DE112019002084T5/de active Pending
- 2019-05-21 CN CN201980028846.7A patent/CN112041935A/zh active Pending
-
2020
- 2020-11-23 US US17/101,867 patent/US20210118539A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003323497A (ja) | 2002-04-30 | 2003-11-14 | Moss Institute Co Ltd | 投薬管理システム及び情報処理装置、投薬管理方法並びにプログラム |
| JP2013105302A (ja) | 2011-11-14 | 2013-05-30 | Mvisual Co Ltd | 調剤薬局システム |
| JP2016531334A (ja) | 2013-06-06 | 2016-10-06 | ヤンセン ファーマシューティカ エヌ.ベー. | 電気的服薬アドヒアランス、識別、及び分配 |
| US20150058035A1 (en) | 2013-08-23 | 2015-02-26 | Ateb, Inc. | Methods, systems and computer program products for automatic periodic prescription fill dates |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019207537A (ja) | 2019-12-05 |
| CN112041935A (zh) | 2020-12-04 |
| DE112019002084T5 (de) | 2021-02-25 |
| WO2019230494A1 (ja) | 2019-12-05 |
| US20210118539A1 (en) | 2021-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7124453B2 (ja) | 投薬管理装置、投薬管理方法及び投薬管理プログラム | |
| US11903743B2 (en) | Method for providing alert of potential thyroid abnormality | |
| US20210118539A1 (en) | Medication management device, medication management method, and non-transitory computer-readable storage medium storing medication management program | |
| JP6868423B2 (ja) | 投薬支援装置、方法及びプログラム | |
| JP7076967B2 (ja) | データ処理装置、データ処理方法及びデータ処理プログラム | |
| JP7119707B2 (ja) | 診断支援装置、診断支援方法及び診断支援プログラム | |
| US20190313983A1 (en) | User terminal apparatus | |
| JP2019003570A (ja) | 健康管理装置、健康管理方法、および健康管理プログラム | |
| JP2018156149A (ja) | 投薬支援装置、方法およびプログラム | |
| CN117795609A (zh) | 诊疗辅助系统、诊疗辅助装置以及程序 | |
| CN116209385A (zh) | 用于心力衰竭患者的治疗性管理的组合物和方法 | |
| US12070328B2 (en) | Wearable personal healthcare sensor apparatus | |
| JP7707655B2 (ja) | 生体情報処理システム、生体情報処理装置、生体情報処理方法及びプログラム | |
| US20240185982A1 (en) | Medical care assistance system, medical care assistance device, and recording medium | |
| CN118742255A (zh) | 用于心力衰竭患者的治疗性管理的组合物和方法 | |
| CN117795608A (zh) | 诊疗辅助系统、诊疗辅助装置以及程序 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210513 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210513 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220726 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220826 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221011 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221024 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7176230 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |